Human leukocyte antigen-G: Immunotolerant major histocompatibility complex molecule in transplantation

World Journal of Surgery

Volumn 24, Issue 7, 2000, Pages 819-822

  Khalil Daher, Iman ^a   Rouas Freiss, Nathalie ^a   Carosella, Edgardo D ^a   Dausset, Jean B ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b Fondation Jean Dausset   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN;

ALTERNATIVE RNA SPLICING; CELL TRANSPLANTATION; CONFERENCE PAPER; COVALENT BOND; IMMUNOLOGICAL TOLERANCE; KILLER CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMBRANE BINDING; PEPTIDE SYNTHESIS; PROTEIN LOCALIZATION; T LYMPHOCYTE ACTIVATION; TISSUE DISTRIBUTION;

GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033918739     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002680010131     Document Type: Conference Paper

References (29)

1. Ishitani, A., Geraghty, D.E.: Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc. Natl. Acad. Sci. U.S.A. 89:3947, 1992
2. Kirszenbaum, M., Moreau, P., Gluckman, E., Dausset, J., Carosella, E.: An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 91:4209, 1994
3. Kirszembaum, M., Djoulah, S., Hors, J., LeGall, J., de Oliveira, E.B., Prost, S., Dausset, J., Carosella, E.D.: HLA-G gene polymorphism segregation within CEPH reference families. Hum. Immunol. 53:140, 1997
4. Kovats, S., Main, E.K., Librach, C., Stubblebine, M., Fisher, S.J., DeMars, R.: A class antigen I. HLA-G, expressed in human trophoblasts. Science. 248:220, 1990
5. Crisa, L., McMaster, M.T., Ishii, J.K., Fisher, S.J., Salomon, D.R.: Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J. Exp. Med. 186:289, 1997
6. Yang, Y., Chu, W., Geraghty, D.E., Hunt, J.S.: Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. J. Immunol. 156:4224, 1996
7. Geraghty, D.E., Koller, B.H., Orr, H.T.: A human major histocompatibility complex class I gene that encodes a protein with shortened cytoplasmic segment. Proc. Natl. Acad. Sci. U.S.A. 84:9145, 1987
8. Diehl, M., Munz, C., Keilholz, W., Stevanovic, S., Holmes, N., Loke, Y.W., Rammensee, H.G.: Nonclassical HLA-G molecules are classical peptide presenters. Curr. Biol. 6:305, 1996
9. Lee, N., Malacko, A.R., Ishitani, A., Chen, M.C., Bajorath, J., Marquardt, H., Geraghty, D.E.: The membrane-bound and soluble forms of HLA-G hind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3:591, 1995
10. Khalil-Daher, I., Riteau, B., Menier, C., Sedlik, C., Paul, P., Dausset, J., Carosella, E.D., Rouas-Freiss, N.: Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. J. Reprod. Immunol. 43:175, 1999
11. Carosella, E.D., Rouas-Freiss, N., Paul, P., Dausset, J.: HLA-G: a tolerance molecule from the major histocompatibility complex. Immunol. Today 20:60, 1999
12. Cantoni, C., Verdiani, S., Falco, M., Pessino, A., Cilli, M., Conte, R., Pende, D., Ponte, M., Mikaelsson, M.S., Moretta, L., Biassoni, R.: p49, a putative HLA class I-specific inhibitory NK receptor belonging to the Ig superfamily. Eur. J. Immunol. 28:1980, 1998
13. Navarro, F., Llano, M., Bellon, T., Colonna, M., Geraghty, D.E., Lopez-Botet, M.: The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 29:277, 1999
14. Rouas-Freiss, N., Marchal, R., Kirszenbaum, M., Dausset, J., Carosella, E.D.: The α1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc. Natl. Acad. Sci. U.S.A. 94:5249, 1997
15. Pazmany, L., Mandelboim, O., Vales-Gomez, M., Davis, D.M., Reyburn, H.T., Strominger, J.L.: Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 274:792, 1996
16. Braud, V.M., Allan, D.S., O'Callaghan, C.A., Soderstrom, K., D'Andrea, A., Ogg, G.S., Lazetic, S., Young, N.T., Bell, J.I., Phillips, J.H., Lanier, L.L., McMichael, A.J.: HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391:795, 1998
17. Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., Lopez-Botet, M., and Geraghty, D.E.: HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. U.S.A. 95:5199, 1998
18. Rouas-Freiss, N., Marchal-Bras Goncalves, R., Menier, C., Dausset, J., Carosella, E.D.: Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl. Acad. Sci. U.S.A. 94:11520, 1997
19. Borrego, F., Ulbrecht, M., Weiss, E.H., Coligan, J.E., Brooks, A.G.: Recognition of human histocompatibility leucocyte antigen (HLA)-E complexed with HLA class 1 signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187:813, 1998
20. Verma, S., King, A., Loke, Y.W. Expression of killer cell inhibitory receptors on human uterine natural killer cells. Eur. J. Immunol. 27:979, 1997
21. Le Gal, F.A., Riteau, B., Sedlik, C., Khalil-Daher, I., Menier, C., Dausset, J., Guillet, J.G., Carosella, E.D., Rouas-Freiss, N.: HLA-G mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 11:1351, 1999
22. Riteau, B., Menier, C., Khalil-Daher, I., Sedlik, C., Dausset, J., Rouas-Freiss, N., Carosella, E.D.: HLA-G inhibits the allogeneic proliferative response. J. Reprod. Immunol. 43:203, 1999
23. Colonna, M., Samaridis, J., Cella, M., Angman, L., Allen, R.L., O'Callaghan, C., Dunbar, R., Ogg, G.S., Cerundolo, V., Rolink, A.: Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J. Immunol. 160:3096, 1998
24. Brand, V., Allan, D., McMichael, A.: Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr. Opin. Immunol. 11: 100, 1999
25. Bach, F.H., Winkler, H., Ferran, C., Hancock, W.W., Robson, S.C.: Delayed xenograft rejection. Immunol. Today 17:979, 1996
26. Scebach, J.D., Comrack, C., Germana, S., LeGuern, C., Sachs, D.H., DerSimonian, H.: HLA-Cw3 expression on porcine endothelial cells protects against xenogencic cytotoxicity mediated by a subset of human NK cells. J. Immunol. 159:3655, 1997
27. Sasaki, H., Xu, X-C., Smith, D.M., Howard, T., Mohanakumar, T.: HLA-G expression protects porcine endothelial cells against natural killer-mediated xenogencic cytotoxicity. Transplantation 57:31, 1999
28. Paul, P., Rouas-Freiss, N., Khalil-Daher, I., Moreau, P., Riteau, B., Anne Le Gal, F., Avril, M.F., Dausset, J., Guillet, J.G., Carosella, E.D.: HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc. Natl. Acad. Sci. U.S.A. 95:4510, 1998
29. Paul, P., Adrian Cabestre, F., Le Gal, F-A., Khalil-Daher I., Le Danff, C., Schmid, M., Mercier, S., Avril, M-F., Dausset, J., Guillet, J-G., Carosella, E.D.: Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies. Cancer Res. 59:1954, 1999